
1. viruses. 2016 jun 15;8(6). pii: e98. doi: 10.3390/v8060098.

identification vimentin potential therapeutic target hiv
infection.

fernández-ortega c(1), ramírez a(2), casillas d(3), paneque t(4), ubieta r(5),
dubed m(6), navea l(7), castellanos-serra l(8), duarte c(9), falcon v(10), reyes 
o(11), garay h(12), silva e(13), noa e(14), ramos y(15), besada v(16), betancourt
l(17).

author information: 
(1)center genetic engineering biotechnology, ave 31/158 190,
cubanac&#225;n, playa, p.o. box 6162, havana 10600, cuba.
celia.fernandez@cigb.edu.cu.
(2)center genetic engineering biotechnology, ave 31/158 190,
cubanac&#225;n, playa, p.o. box 6162, havana 10600, cuba.
anna.ramirez@cigb.edu.cu.
(3)center genetic engineering biotechnology, ave 31/158 190,
cubanac&#225;n, playa, p.o. box 6162, havana 10600, cuba.
dionne.casillas@cigb.edu.cu.
(4)center genetic engineering biotechnology, ave 31/158 190,
cubanac&#225;n, playa, p.o. box 6162, havana 10600, cuba.
taimi.paneque@cigb.edu.cu.
(5)center genetic engineering biotechnology, ave 31/158 190,
cubanac&#225;n, playa, p.o. box 6162, havana 10600, cuba.
raimundo.ubieta@cigb.edu.cu.
(6)laboratory aids research, carretera de tapaste autopista nacional, san
jos&#233; de las lajas, mayabeque cp 32700, cuba. cicdc@infomed.sld.cu.
(7)laboratory aids research, carretera de tapaste autopista nacional, san
jos&#233; de las lajas, mayabeque cp 32700, cuba. riverora@infomed.sld.cu.
(8)center genetic engineering biotechnology, ave 31/158 190,
cubanac&#225;n, playa, p.o. box 6162, havana 10600, cuba.
lilacastellanos@infomed.sld.cu.
(9)center genetic engineering biotechnology, ave 31/158 190,
cubanac&#225;n, playa, p.o. box 6162, havana 10600, cuba.
carlos.duarte@cigb.edu.cu.
(10)center genetic engineering biotechnology, ave 31/158 190,
cubanac&#225;n, playa, p.o. box 6162, havana 10600, cuba.
viviana.falcon@cigb.edu.cu.
(11)center genetic engineering biotechnology, ave 31/158 190,
cubanac&#225;n, playa, p.o. box 6162, havana 10600, cuba.
osvaldo.reyes@cigb.edu.cu.
(12)center genetic engineering biotechnology, ave 31/158 190,
cubanac&#225;n, playa, p.o. box 6162, havana 10600, cuba.
hilda.garay@cigb.edu.cu.
(13)laboratory aids research, carretera de tapaste autopista nacional, san 
jos&#233; de las lajas, mayabeque cp 32700, cuba. eladio.silva@infomed.sld.cu.
(14)laboratory aids research, carretera de tapaste autopista nacional, san 
jos&#233; de las lajas, mayabeque cp 32700, cuba. enrnoa@infomed.sld.cu.
(15)center genetic engineering biotechnology, ave 31/158 190,
cubanac&#225;n, playa, p.o. box 6162, havana 10600, cuba.
yassel.ramos@cigb.edu.cu.
(16)center genetic engineering biotechnology, ave 31/158 190,
cubanac&#225;n, playa, p.o. box 6162, havana 10600, cuba.
vladimir.besada@cigb.edu.cu.
(17)center genetic engineering biotechnology, ave 31/158 190,
cubanac&#225;n, playa, p.o. box 6162, havana 10600, cuba.
lazaro.betancourt@cigb.edu.cu.

a combination antiviral drugs known antiretroviral therapy (art) shown 
effectiveness human immunodeficiency virus (hiv). art markedly
decreased mortality morbidity among hiv-infected patients, even
reduced hiv transmission. however, important current disadvantage, resistance 
development, remains solved. hope focused developing drugs against
cellular targets. strategy expected prevent emergence viral
resistance. study, using comparative proteomic approach mt4 cells
treated anti-hiv leukocyte extract, identified vimentin, molecule
forming intermediate filaments cell, possible target hiv
infection. demonstrated strong reduction hiv-1 based lentivirus
expressing enhanced green fluorescent protein (egfp) vimentin knockdown
cells, noteworthy decrease hiv-1 capsid protein antigen (cap24) those
cells using multiround infectivity assay. electron micrographs showed changes
in structure intermediate filaments mt4 cells treated an
anti-hiv leukocyte extract. changes structure intermediate filaments
were also observed vimentin knockdown mt4 cells. synthetic peptide derived
from cytoskeleton protein showed potent inhibitory activity hiv-1 infection,
and low cytotoxicity. data suggest vimentin suitable target 
inhibit hiv-1.

doi: 10.3390/v8060098 
pmcid: pmc4926169
pmid: 27314381  [indexed medline]

